Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286


Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review.

Pin TW, Elmasry J, Lewis J.

Dev Med Child Neurol. 2013 Apr;55(4):304-13. doi: 10.1111/j.1469-8749.2012.04438.x. Epub 2012 Oct 24. Review.


Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review.

Pin TW, McCartney L, Lewis J, Waugh MC.

Dev Med Child Neurol. 2011 Oct;53(10):885-95. doi: 10.1111/j.1469-8749.2011.03992.x. Epub 2011 Jun 3. Review. Erratum in: Dev Med Child Neurol. 2011 Nov;53(11):1065.


Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.

Lundy CT, Doherty GM, Fairhurst CB.

Dev Med Child Neurol. 2009 Sep;51(9):705-10. doi: 10.1111/j.1469-8749.2009.03315.x. Epub 2009 Apr 21.


Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003469. doi: 10.1002/14651858.CD003469.pub4. Review.


Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.

Lukban MB, Rosales RL, Dressler D.

J Neural Transm (Vienna). 2009 Mar;116(3):319-31. doi: 10.1007/s00702-008-0175-8. Epub 2009 Jan 14. Review.


Botulinum neurotoxin treatment in children with cerebral palsy: a population-based study in Norway.

Elkamil AI, Andersen GL, Skranes J, Lamvik T, Vik T.

Eur J Paediatr Neurol. 2012 Sep;16(5):522-7. doi: 10.1016/j.ejpn.2012.01.008. Epub 2012 Feb 10.


Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.

Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S.

Disabil Rehabil. 2013 Apr;35(7):596-605. doi: 10.3109/09638288.2012.711898. Epub 2012 Aug 28.


Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy.

Williams SA, Reid S, Elliott C, Shipman P, Valentine J.

Dev Med Child Neurol. 2013 Sep;55(9):813-20. doi: 10.1111/dmcn.12200. Epub 2013 Jun 22.


[Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].

Deleplanque B, Lagueny A, Flurin V, Arnaud C, Pedespan JM, Fontan D, Pontallier JR.

Rev Chir Orthop Reparatrice Appar Mot. 2002 May;88(3):279-85. French.


Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.

Thorley M, Donaghey S, Edwards P, Copeland L, Kentish M, McLennan K, Lindsley J, Gascoigne-Pees L, Sakzewski L, Boyd RN.

BMC Pediatr. 2012 Aug 9;12:120. doi: 10.1186/1471-2431-12-120.


Longitudinal development of gross motor function among Dutch children and young adults with cerebral palsy: an investigation of motor growth curves.

Smits DW, Gorter JW, Hanna SE, Dallmeijer AJ, van Eck M, Roebroeck ME, Vos RC, Ketelaar M; PERRIN Plus Study Group.

Dev Med Child Neurol. 2013 Apr;55(4):378-84. doi: 10.1111/dmcn.12083. Epub 2013 Jan 29.


Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.

Koman LA, Smith BP, Williams R, Richardson R, Naughton M, Griffin L, Evans P.

J Hand Surg Am. 2013 Mar;38(3):435-46.e1. doi: 10.1016/j.jhsa.2012.12.019.


Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.

Ade-Hall RA, Moore AP.

Cochrane Database Syst Rev. 2000;(2):CD001408. Review.


Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.

Copeland L, Edwards P, Thorley M, Donaghey S, Gascoigne-Pees L, Kentish M, Cert G, Lindsley J, McLennan K, Sakzewski L, Boyd RN.

J Pediatr. 2014 Jul;165(1):140-146.e4. doi: 10.1016/j.jpeds.2014.01.050. Epub 2014 Mar 12.


The impact of botulinum toxin A and abduction bracing on long-term hip development in children with cerebral palsy.

Willoughby K, Ang SG, Thomason P, Graham HK.

Dev Med Child Neurol. 2012 Aug;54(8):743-7. doi: 10.1111/j.1469-8749.2012.04340.x. Epub 2012 Jun 12.


A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.

Chaléat-Valayer E, Parratte B, Colin C, Denis A, Oudin S, Bérard C, Bernard JC, Bourg V, Deleplanque B, Dulieu I, Evrard P, Filipetti P, Flurin V, Gallien P, Héron-Long B, Hodgkinson I, Husson I, Jaisson-Hot I, Maupas E, Meurin F, Monnier G, Pérennou D, Pialoux B, Quentin V, Moreau MS, Schneider M, Yelnik A, Marque P.

Eur J Paediatr Neurol. 2011 Sep;15(5):439-48. doi: 10.1016/j.ejpn.2010.04.006. Epub 2011 Jul 13.


No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.

Alhusaini AA, Crosbie J, Shepherd RB, Dean CM, Scheinberg A.

Dev Med Child Neurol. 2011 Jun;53(6):553-8. doi: 10.1111/j.1469-8749.2011.03930.x.


Off label use of botulinum toxin in children under two years of age: a systematic review.

Druschel C, Althuizes HC, Funk JF, Placzek R.

Toxins (Basel). 2013 Jan 7;5(1):60-72. doi: 10.3390/toxins5010060. Review.


Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review.

Mergler S, Evenhuis HM, Boot AM, De Man SA, Bindels-De Heus KG, Huijbers WA, Penning C.

Dev Med Child Neurol. 2009 Oct;51(10):773-8. doi: 10.1111/j.1469-8749.2009.03384.x. Epub 2009 Jul 8. Review.

Items per page

Supplemental Content

Write to the Help Desk